HEADER VIRAL PROTEIN 06-OCT-22 8H2J TITLE STRUCTURE OF ACB2 COMPLEXED WITH 3',3'-CGAMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: P26; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS PHAGE PAP2; SOURCE 3 ORGANISM_TAXID: 270673; SOURCE 4 GENE: ORF26; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.FENG,X.L.CAO REVDAT 3 03-APR-24 8H2J 1 REMARK REVDAT 2 08-MAR-23 8H2J 1 JRNL REVDAT 1 22-FEB-23 8H2J 0 JRNL AUTH E.HUITING,X.CAO,J.REN,J.S.ATHUKORALAGE,Z.LUO,S.SILAS,N.AN, JRNL AUTH 2 H.CARION,Y.ZHOU,J.S.FRASER,Y.FENG,J.BONDY-DENOMY JRNL TITL BACTERIOPHAGES INHIBIT AND EVADE CGAS-LIKE IMMUNE FUNCTION JRNL TITL 2 IN BACTERIA. JRNL REF CELL V. 186 864 2023 JRNL REFN ISSN 1097-4172 JRNL PMID 36750095 JRNL DOI 10.1016/J.CELL.2022.12.041 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1-4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 24151 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.4900 - 2.4000 0.00 0 120 0.2976 0.3574 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8H2J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 11-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300032684. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-X REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : RIGAKU HYPIX-6000HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24846 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 12.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 22.30 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: ALPHAFOLD2 MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM BROMIDE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 203.19200 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 203.19200 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 203.19200 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 101.59600 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 101.59600 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 101.59600 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -103.46400 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -51.73200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 -89.60245 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -103.46400 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -51.73200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 -89.60245 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 206 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 235 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 240 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 222 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 223 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 MET C 1 REMARK 465 ASP C 2 REMARK 465 MET D 1 REMARK 465 ASP D 2 REMARK 465 MET E 1 REMARK 465 ASP E 2 REMARK 465 MET F 1 REMARK 465 ASP F 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN E 4 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 89 74.54 55.59 REMARK 500 GLN B 89 76.74 56.83 REMARK 500 GLN C 89 80.69 56.01 REMARK 500 GLN D 89 79.53 48.16 REMARK 500 GLN E 89 80.57 54.32 REMARK 500 GLN F 89 80.30 57.56 REMARK 500 REMARK 500 REMARK: NULL DBREF 8H2J A 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H2J B 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H2J C 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H2J D 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H2J E 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 DBREF 8H2J F 1 93 UNP Q6PVL0 Q6PVL0_9CAUD 1 93 SEQRES 1 A 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 A 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 A 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 A 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 A 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 A 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 A 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 A 93 SER PHE SEQRES 1 B 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 B 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 B 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 B 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 B 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 B 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 B 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 B 93 SER PHE SEQRES 1 C 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 C 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 C 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 C 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 C 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 C 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 C 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 C 93 SER PHE SEQRES 1 D 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 D 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 D 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 D 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 D 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 D 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 D 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 D 93 SER PHE SEQRES 1 E 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 E 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 E 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 E 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 E 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 E 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 E 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 E 93 SER PHE SEQRES 1 F 93 MET ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP SEQRES 2 F 93 LEU SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS SEQRES 3 F 93 GLU LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SEQRES 4 F 93 SER ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS SEQRES 5 F 93 ASN ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO SEQRES 6 F 93 GLY ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR SEQRES 7 F 93 GLY MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SEQRES 8 F 93 SER PHE HET 4BW A 101 45 HET 4BW B 101 45 HET 4BW D 101 45 HET 4BW E 101 45 HETNAM 4BW 2-AMINO-9-[(2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-9- HETNAM 2 4BW (6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12- HETNAM 3 4BW DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9, HETNAM 4 4BW 2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO- HETNAM 5 4BW 6H-PURIN-6-ONE HETSYN 4BW 3',3' CGAMP; C-GMP-AMP; C[G(3',5')PA(3',5')P] FORMUL 7 4BW 4(C20 H24 N10 O13 P2) FORMUL 11 HOH *128(H2 O) HELIX 1 AA1 ASN A 3 ILE A 8 5 6 HELIX 2 AA2 SER A 15 SER A 50 1 36 HELIX 3 AA3 ASN A 53 GLU A 64 1 12 HELIX 4 AA4 GLU A 64 GLN A 89 1 26 HELIX 5 AA5 ASN B 3 ILE B 8 5 6 HELIX 6 AA6 SER B 15 SER B 50 1 36 HELIX 7 AA7 ASN B 53 GLU B 64 1 12 HELIX 8 AA8 GLU B 64 GLN B 89 1 26 HELIX 9 AA9 GLN C 4 ILE C 8 5 5 HELIX 10 AB1 SER C 15 SER C 50 1 36 HELIX 11 AB2 ASN C 53 GLU C 64 1 12 HELIX 12 AB3 GLU C 64 GLN C 89 1 26 HELIX 13 AB4 ASN D 3 ILE D 8 5 6 HELIX 14 AB5 SER D 15 SER D 50 1 36 HELIX 15 AB6 ASN D 53 GLU D 64 1 12 HELIX 16 AB7 GLU D 64 GLN D 89 1 26 HELIX 17 AB8 GLN E 4 ILE E 8 5 5 HELIX 18 AB9 SER E 15 SER E 50 1 36 HELIX 19 AC1 ASN E 53 GLU E 64 1 12 HELIX 20 AC2 GLU E 64 GLN E 89 1 26 HELIX 21 AC3 SER F 15 SER F 50 1 36 HELIX 22 AC4 ASN F 53 GLU F 64 1 12 HELIX 23 AC5 GLU F 64 GLN F 89 1 26 CRYST1 103.464 103.464 101.596 90.00 90.00 120.00 P 3 2 1 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009665 0.005580 0.000000 0.00000 SCALE2 0.000000 0.011160 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009843 0.00000